172 related articles for article (PubMed ID: 21277173)
1. The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.
Holly EN; Ebrecht B; Prus AJ
Eur Neuropsychopharmacol; 2011 Jul; 21(7):526-31. PubMed ID: 21277173
[TBL] [Abstract][Full Text] [Related]
2. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
Chou S; Davis C; Jones S; Li M
Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
[TBL] [Abstract][Full Text] [Related]
3. Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats.
Prus AJ; Hillhouse TM; LaCrosse AL
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():78-84. PubMed ID: 24275076
[TBL] [Abstract][Full Text] [Related]
4. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
Feifel D; Melendez G; Murray RJ; Tina Tran DN; Rullan MA; Shilling PD
Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
[TBL] [Abstract][Full Text] [Related]
5. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
Prus AJ; Schuck CJ; Rusch KR; Carey LM
Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
[TBL] [Abstract][Full Text] [Related]
6. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Shilling PD; Richelson E; Feifel D
Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
[TBL] [Abstract][Full Text] [Related]
8. Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance.
Murphy CA; Feldon J
Behav Pharmacol; 2000 Jun; 11(3-4):307-16. PubMed ID: 11103885
[TBL] [Abstract][Full Text] [Related]
9. WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.
Grauer SM; Graf R; Navarra R; Sung A; Logue SF; Stack G; Huselton C; Liu Z; Comery TA; Marquis KL; Rosenzweig-Lipson S
Psychopharmacology (Berl); 2009 May; 204(1):37-48. PubMed ID: 19107466
[TBL] [Abstract][Full Text] [Related]
10. Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in rats.
Hillhouse TM; Prus AJ
Eur J Pharmacol; 2013 Dec; 721(1-3):201-7. PubMed ID: 24076181
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Neuropsychopharmacology; 2007 Jul; 32(7):1540-9. PubMed ID: 17164815
[TBL] [Abstract][Full Text] [Related]
12. Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats.
Feifel D; Shilling PD; Melendez G
Behav Neurosci; 2011 Apr; 125(2):268-72. PubMed ID: 21463026
[TBL] [Abstract][Full Text] [Related]
13. The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog.
Feifel D; Mexal S; Melendez G; Liu PY; Goldenberg JR; Shilling PD
Neuropsychopharmacology; 2009 Jul; 34(8):2011-8. PubMed ID: 19322170
[TBL] [Abstract][Full Text] [Related]
14. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects.
Feifel D; Melendez G; Shilling PD
Neuropsychopharmacology; 2004 Apr; 29(4):731-8. PubMed ID: 14760394
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic-like effects of a neurotensin receptor type 1 agonist.
Vadnie CA; Ayers-Ringler J; Oliveros A; Abulseoud OA; Choi S; Hitschfeld MJ; Choi DS
Behav Brain Res; 2016 May; 305():8-17. PubMed ID: 26909848
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats.
Keiser AA; Matazel KS; Esser MK; Feifel D; Prus AJ
Exp Clin Psychopharmacol; 2014 Dec; 22(6):541-7. PubMed ID: 25222546
[TBL] [Abstract][Full Text] [Related]
17. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Ward RP; Dorsa DM
Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.
Idris NF; Repeto P; Neill JC; Large CH
Psychopharmacology (Berl); 2005 May; 179(2):336-48. PubMed ID: 15645224
[TBL] [Abstract][Full Text] [Related]
20. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Wadenberg MG; Browning JL; Young KA; Hicks PB
Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
